Targeting Redox Regulation as a Therapeutic Opportunity against Acute Leukemia: Pro-Oxidant Strategy or Antioxidant Approach?
Redox adaptation is essential for human health, as the physiological quantities of non-radical reactive oxygen species operate as the main second messengers to regulate normal redox reactions by controlling several sensors. An abnormal increase reactive oxygen species, called oxidative stress, induc...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/11/9/1696 |
_version_ | 1797491725779861504 |
---|---|
author | Alessandro Allegra Alessandro Tonacci Laura Giordano Caterina Musolino Sebastiano Gangemi |
author_facet | Alessandro Allegra Alessandro Tonacci Laura Giordano Caterina Musolino Sebastiano Gangemi |
author_sort | Alessandro Allegra |
collection | DOAJ |
description | Redox adaptation is essential for human health, as the physiological quantities of non-radical reactive oxygen species operate as the main second messengers to regulate normal redox reactions by controlling several sensors. An abnormal increase reactive oxygen species, called oxidative stress, induces biological injury. For this reason, variations in oxidative stress continue to receive consideration as a possible approach to treat leukemic diseases. However, the intricacy of redox reactions and their effects might be a relevant obstacle; consequently, and alongside approaches aimed at increasing oxidative stress in neoplastic cells, antioxidant strategies have also been suggested for the same purpose. The present review focuses on the molecular processes of anomalous oxidative stress in acute myeloid and acute lymphoblastic leukemias as well as on the oxidative stress-determined pathways implicated in leukemogenic development. Furthermore, we review the effect of chemotherapies on oxidative stress and the possibility that their pharmacological effects might be increased by modifying the intracellular redox equilibrium through a pro-oxidant approach or an antioxidant strategy. Finally, we evaluated the prospect of varying oxidative stress as an efficacious modality to destroy chemoresistant cells using new methodologies. Altering redox conditions may be advantageous for inhibiting genomic variability and the eradication of leukemic clones will promote the treatment of leukemic disease. |
first_indexed | 2024-03-10T00:53:28Z |
format | Article |
id | doaj.art-08101d0c45774bb9ad604d79ccafab93 |
institution | Directory Open Access Journal |
issn | 2076-3921 |
language | English |
last_indexed | 2024-03-10T00:53:28Z |
publishDate | 2022-08-01 |
publisher | MDPI AG |
record_format | Article |
series | Antioxidants |
spelling | doaj.art-08101d0c45774bb9ad604d79ccafab932023-11-23T14:47:25ZengMDPI AGAntioxidants2076-39212022-08-01119169610.3390/antiox11091696Targeting Redox Regulation as a Therapeutic Opportunity against Acute Leukemia: Pro-Oxidant Strategy or Antioxidant Approach?Alessandro Allegra0Alessandro Tonacci1Laura Giordano2Caterina Musolino3Sebastiano Gangemi4Division of Hematology, Department of Human Pathology in Adulthood and Childhood “Gaetano Barresi”, University of Messina, 98125 Messina, ItalyClinical Physiology Institute, National Research Council of Italy (IFC-CNR), 56124 Pisa, ItalyDivision of Hematology, Department of Human Pathology in Adulthood and Childhood “Gaetano Barresi”, University of Messina, 98125 Messina, ItalyDivision of Hematology, Department of Human Pathology in Adulthood and Childhood “Gaetano Barresi”, University of Messina, 98125 Messina, ItalyAllergy and Clinical Immunology Unit, Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, ItalyRedox adaptation is essential for human health, as the physiological quantities of non-radical reactive oxygen species operate as the main second messengers to regulate normal redox reactions by controlling several sensors. An abnormal increase reactive oxygen species, called oxidative stress, induces biological injury. For this reason, variations in oxidative stress continue to receive consideration as a possible approach to treat leukemic diseases. However, the intricacy of redox reactions and their effects might be a relevant obstacle; consequently, and alongside approaches aimed at increasing oxidative stress in neoplastic cells, antioxidant strategies have also been suggested for the same purpose. The present review focuses on the molecular processes of anomalous oxidative stress in acute myeloid and acute lymphoblastic leukemias as well as on the oxidative stress-determined pathways implicated in leukemogenic development. Furthermore, we review the effect of chemotherapies on oxidative stress and the possibility that their pharmacological effects might be increased by modifying the intracellular redox equilibrium through a pro-oxidant approach or an antioxidant strategy. Finally, we evaluated the prospect of varying oxidative stress as an efficacious modality to destroy chemoresistant cells using new methodologies. Altering redox conditions may be advantageous for inhibiting genomic variability and the eradication of leukemic clones will promote the treatment of leukemic disease.https://www.mdpi.com/2076-3921/11/9/1696oxidative stressacute myeloid leukemiaacute lymphoblastic leukemiareactive oxygen speciesmitochondria |
spellingShingle | Alessandro Allegra Alessandro Tonacci Laura Giordano Caterina Musolino Sebastiano Gangemi Targeting Redox Regulation as a Therapeutic Opportunity against Acute Leukemia: Pro-Oxidant Strategy or Antioxidant Approach? Antioxidants oxidative stress acute myeloid leukemia acute lymphoblastic leukemia reactive oxygen species mitochondria |
title | Targeting Redox Regulation as a Therapeutic Opportunity against Acute Leukemia: Pro-Oxidant Strategy or Antioxidant Approach? |
title_full | Targeting Redox Regulation as a Therapeutic Opportunity against Acute Leukemia: Pro-Oxidant Strategy or Antioxidant Approach? |
title_fullStr | Targeting Redox Regulation as a Therapeutic Opportunity against Acute Leukemia: Pro-Oxidant Strategy or Antioxidant Approach? |
title_full_unstemmed | Targeting Redox Regulation as a Therapeutic Opportunity against Acute Leukemia: Pro-Oxidant Strategy or Antioxidant Approach? |
title_short | Targeting Redox Regulation as a Therapeutic Opportunity against Acute Leukemia: Pro-Oxidant Strategy or Antioxidant Approach? |
title_sort | targeting redox regulation as a therapeutic opportunity against acute leukemia pro oxidant strategy or antioxidant approach |
topic | oxidative stress acute myeloid leukemia acute lymphoblastic leukemia reactive oxygen species mitochondria |
url | https://www.mdpi.com/2076-3921/11/9/1696 |
work_keys_str_mv | AT alessandroallegra targetingredoxregulationasatherapeuticopportunityagainstacuteleukemiaprooxidantstrategyorantioxidantapproach AT alessandrotonacci targetingredoxregulationasatherapeuticopportunityagainstacuteleukemiaprooxidantstrategyorantioxidantapproach AT lauragiordano targetingredoxregulationasatherapeuticopportunityagainstacuteleukemiaprooxidantstrategyorantioxidantapproach AT caterinamusolino targetingredoxregulationasatherapeuticopportunityagainstacuteleukemiaprooxidantstrategyorantioxidantapproach AT sebastianogangemi targetingredoxregulationasatherapeuticopportunityagainstacuteleukemiaprooxidantstrategyorantioxidantapproach |